Niagen Bioscience Increases Buyback Plan From $10M To $20M

Niagen Bioscience, Inc. (NASDAQ: NAGE) has announced an increase in its share repurchase program from $10 million to $20 million. As of March 17, 2026, the company has repurchased approximately $2.6 million of its common stock under this program. Further details on share repurchases will be included in the company's periodic reports filed with the SEC.